世界の副甲状腺機能低下症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Hypoparathyroidism Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4341
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、副甲状腺機能低下症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、非経口）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・副甲状腺機能低下症治療の市場動向
・企業の競争状況、市場シェア
・副甲状腺機能低下症治療の種類別市場規模と予測2016-2027（経口、非経口）
・副甲状腺機能低下症治療の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局）
・副甲状腺機能低下症治療の北米市場規模2016-2027（アメリカ、カナダ）
・副甲状腺機能低下症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・副甲状腺機能低下症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・副甲状腺機能低下症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・副甲状腺機能低下症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Takeda、Roche、Entera Bio、Teva Pharmaceuticals、Sun Pharmaceutical、AbbVie、GlaxoSmithKline、Takeda Pharmaceutical）
・結論

Market Analysis and Insights: Global Hypoparathyroidism Treatment Market
The global Hypoparathyroidism Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hypoparathyroidism Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hypoparathyroidism Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hypoparathyroidism Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hypoparathyroidism Treatment market.

Global Hypoparathyroidism Treatment Scope and Market Size
Hypoparathyroidism Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hypoparathyroidism Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral
Parenteral

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Takeda
Roche
Entera Bio
Teva Pharmaceuticals
Sun Pharmaceutical
AbbVie
GlaxoSmithKline
Takeda Pharmaceutical

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hypoparathyroidism Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Parenteral
1.3 Market by Application
1.3.1 Global Hypoparathyroidism Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hypoparathyroidism Treatment Market Perspective (2016-2027)
2.2 Hypoparathyroidism Treatment Growth Trends by Regions
2.2.1 Hypoparathyroidism Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hypoparathyroidism Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Hypoparathyroidism Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Hypoparathyroidism Treatment Industry Dynamic
2.3.1 Hypoparathyroidism Treatment Market Trends
2.3.2 Hypoparathyroidism Treatment Market Drivers
2.3.3 Hypoparathyroidism Treatment Market Challenges
2.3.4 Hypoparathyroidism Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hypoparathyroidism Treatment Players by Revenue
3.1.1 Global Top Hypoparathyroidism Treatment Players by Revenue (2016-2021)
3.1.2 Global Hypoparathyroidism Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Hypoparathyroidism Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hypoparathyroidism Treatment Revenue
3.4 Global Hypoparathyroidism Treatment Market Concentration Ratio
3.4.1 Global Hypoparathyroidism Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hypoparathyroidism Treatment Revenue in 2020
3.5 Hypoparathyroidism Treatment Key Players Head office and Area Served
3.6 Key Players Hypoparathyroidism Treatment Product Solution and Service
3.7 Date of Enter into Hypoparathyroidism Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hypoparathyroidism Treatment Breakdown Data by Type
4.1 Global Hypoparathyroidism Treatment Historic Market Size by Type (2016-2021)
4.2 Global Hypoparathyroidism Treatment Forecasted Market Size by Type (2022-2027)

5 Hypoparathyroidism Treatment Breakdown Data by Application
5.1 Global Hypoparathyroidism Treatment Historic Market Size by Application (2016-2021)
5.2 Global Hypoparathyroidism Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hypoparathyroidism Treatment Market Size (2016-2027)
6.2 North America Hypoparathyroidism Treatment Market Size by Type
6.2.1 North America Hypoparathyroidism Treatment Market Size by Type (2016-2021)
6.2.2 North America Hypoparathyroidism Treatment Market Size by Type (2022-2027)
6.2.3 North America Hypoparathyroidism Treatment Market Size by Type (2016-2027)
6.3 North America Hypoparathyroidism Treatment Market Size by Application
6.3.1 North America Hypoparathyroidism Treatment Market Size by Application (2016-2021)
6.3.2 North America Hypoparathyroidism Treatment Market Size by Application (2022-2027)
6.3.3 North America Hypoparathyroidism Treatment Market Size by Application (2016-2027)
6.4 North America Hypoparathyroidism Treatment Market Size by Country
6.4.1 North America Hypoparathyroidism Treatment Market Size by Country (2016-2021)
6.4.2 North America Hypoparathyroidism Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Hypoparathyroidism Treatment Market Size (2016-2027)
7.2 Europe Hypoparathyroidism Treatment Market Size by Type
7.2.1 Europe Hypoparathyroidism Treatment Market Size by Type (2016-2021)
7.2.2 Europe Hypoparathyroidism Treatment Market Size by Type (2022-2027)
7.2.3 Europe Hypoparathyroidism Treatment Market Size by Type (2016-2027)
7.3 Europe Hypoparathyroidism Treatment Market Size by Application
7.3.1 Europe Hypoparathyroidism Treatment Market Size by Application (2016-2021)
7.3.2 Europe Hypoparathyroidism Treatment Market Size by Application (2022-2027)
7.3.3 Europe Hypoparathyroidism Treatment Market Size by Application (2016-2027)
7.4 Europe Hypoparathyroidism Treatment Market Size by Country
7.4.1 Europe Hypoparathyroidism Treatment Market Size by Country (2016-2021)
7.4.2 Europe Hypoparathyroidism Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hypoparathyroidism Treatment Market Size (2016-2027)
8.2 Asia-Pacific Hypoparathyroidism Treatment Market Size by Type
8.2.1 Asia-Pacific Hypoparathyroidism Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hypoparathyroidism Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hypoparathyroidism Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Hypoparathyroidism Treatment Market Size by Application
8.3.1 Asia-Pacific Hypoparathyroidism Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hypoparathyroidism Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hypoparathyroidism Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Hypoparathyroidism Treatment Market Size by Region
8.4.1 Asia-Pacific Hypoparathyroidism Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hypoparathyroidism Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hypoparathyroidism Treatment Market Size (2016-2027)
9.2 Latin America Hypoparathyroidism Treatment Market Size by Type
9.2.1 Latin America Hypoparathyroidism Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Hypoparathyroidism Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Hypoparathyroidism Treatment Market Size by Type (2016-2027)
9.3 Latin America Hypoparathyroidism Treatment Market Size by Application
9.3.1 Latin America Hypoparathyroidism Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Hypoparathyroidism Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Hypoparathyroidism Treatment Market Size by Application (2016-2027)
9.4 Latin America Hypoparathyroidism Treatment Market Size by Country
9.4.1 Latin America Hypoparathyroidism Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Hypoparathyroidism Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hypoparathyroidism Treatment Market Size (2016-2027)
10.2 Middle East & Africa Hypoparathyroidism Treatment Market Size by Type
10.2.1 Middle East & Africa Hypoparathyroidism Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hypoparathyroidism Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hypoparathyroidism Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Hypoparathyroidism Treatment Market Size by Application
10.3.1 Middle East & Africa Hypoparathyroidism Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hypoparathyroidism Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hypoparathyroidism Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Hypoparathyroidism Treatment Market Size by Country
10.4.1 Middle East & Africa Hypoparathyroidism Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hypoparathyroidism Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Details
11.1.2 Takeda Business Overview
11.1.3 Takeda Hypoparathyroidism Treatment Introduction
11.1.4 Takeda Revenue in Hypoparathyroidism Treatment Business (2016-2021)
11.1.5 Takeda Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Hypoparathyroidism Treatment Introduction
11.2.4 Roche Revenue in Hypoparathyroidism Treatment Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Entera Bio
11.3.1 Entera Bio Company Details
11.3.2 Entera Bio Business Overview
11.3.3 Entera Bio Hypoparathyroidism Treatment Introduction
11.3.4 Entera Bio Revenue in Hypoparathyroidism Treatment Business (2016-2021)
11.3.5 Entera Bio Recent Development
11.4 Teva Pharmaceuticals
11.4.1 Teva Pharmaceuticals Company Details
11.4.2 Teva Pharmaceuticals Business Overview
11.4.3 Teva Pharmaceuticals Hypoparathyroidism Treatment Introduction
11.4.4 Teva Pharmaceuticals Revenue in Hypoparathyroidism Treatment Business (2016-2021)
11.4.5 Teva Pharmaceuticals Recent Development
11.5 Sun Pharmaceutical
11.5.1 Sun Pharmaceutical Company Details
11.5.2 Sun Pharmaceutical Business Overview
11.5.3 Sun Pharmaceutical Hypoparathyroidism Treatment Introduction
11.5.4 Sun Pharmaceutical Revenue in Hypoparathyroidism Treatment Business (2016-2021)
11.5.5 Sun Pharmaceutical Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Hypoparathyroidism Treatment Introduction
11.6.4 AbbVie Revenue in Hypoparathyroidism Treatment Business (2016-2021)
11.6.5 AbbVie Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Hypoparathyroidism Treatment Introduction
11.7.4 GlaxoSmithKline Revenue in Hypoparathyroidism Treatment Business (2016-2021)
11.7.5 GlaxoSmithKline Recent Development
11.8 Takeda Pharmaceutical
11.8.1 Takeda Pharmaceutical Company Details
11.8.2 Takeda Pharmaceutical Business Overview
11.8.3 Takeda Pharmaceutical Hypoparathyroidism Treatment Introduction
11.8.4 Takeda Pharmaceutical Revenue in Hypoparathyroidism Treatment Business (2016-2021)
11.8.5 Takeda Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hypoparathyroidism Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Parenteral
Table 4. Global Hypoparathyroidism Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Hypoparathyroidism Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Hypoparathyroidism Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Hypoparathyroidism Treatment Market Share by Regions (2016-2021)
Table 8. Global Hypoparathyroidism Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Hypoparathyroidism Treatment Market Share by Regions (2022-2027)
Table 10. Hypoparathyroidism Treatment Market Trends
Table 11. Hypoparathyroidism Treatment Market Drivers
Table 12. Hypoparathyroidism Treatment Market Challenges
Table 13. Hypoparathyroidism Treatment Market Restraints
Table 14. Global Hypoparathyroidism Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Hypoparathyroidism Treatment Market Share by Players (2016-2021)
Table 16. Global Top Hypoparathyroidism Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypoparathyroidism Treatment as of 2020)
Table 17. Ranking of Global Top Hypoparathyroidism Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Hypoparathyroidism Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hypoparathyroidism Treatment Product Solution and Service
Table 21. Date of Enter into Hypoparathyroidism Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hypoparathyroidism Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Hypoparathyroidism Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Hypoparathyroidism Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Hypoparathyroidism Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Hypoparathyroidism Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Hypoparathyroidism Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Hypoparathyroidism Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Hypoparathyroidism Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Hypoparathyroidism Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Hypoparathyroidism Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Hypoparathyroidism Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Hypoparathyroidism Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Hypoparathyroidism Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Hypoparathyroidism Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Hypoparathyroidism Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Hypoparathyroidism Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Hypoparathyroidism Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Hypoparathyroidism Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Hypoparathyroidism Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Hypoparathyroidism Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Hypoparathyroidism Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Hypoparathyroidism Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Hypoparathyroidism Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Hypoparathyroidism Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Hypoparathyroidism Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Hypoparathyroidism Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Hypoparathyroidism Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Hypoparathyroidism Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Hypoparathyroidism Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Hypoparathyroidism Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Hypoparathyroidism Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Hypoparathyroidism Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Hypoparathyroidism Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Hypoparathyroidism Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Hypoparathyroidism Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Hypoparathyroidism Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Hypoparathyroidism Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Hypoparathyroidism Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Takeda Company Details
Table 62. Takeda Business Overview
Table 63. Takeda Hypoparathyroidism Treatment Product
Table 64. Takeda Revenue in Hypoparathyroidism Treatment Business (2016-2021) & (US$ Million)
Table 65. Takeda Recent Development
Table 66. Roche Company Details
Table 67. Roche Business Overview
Table 68. Roche Hypoparathyroidism Treatment Product
Table 69. Roche Revenue in Hypoparathyroidism Treatment Business (2016-2021) & (US$ Million)
Table 70. Roche Recent Development
Table 71. Entera Bio Company Details
Table 72. Entera Bio Business Overview
Table 73. Entera Bio Hypoparathyroidism Treatment Product
Table 74. Entera Bio Revenue in Hypoparathyroidism Treatment Business (2016-2021) & (US$ Million)
Table 75. Entera Bio Recent Development
Table 76. Teva Pharmaceuticals Company Details
Table 77. Teva Pharmaceuticals Business Overview
Table 78. Teva Pharmaceuticals Hypoparathyroidism Treatment Product
Table 79. Teva Pharmaceuticals Revenue in Hypoparathyroidism Treatment Business (2016-2021) & (US$ Million)
Table 80. Teva Pharmaceuticals Recent Development
Table 81. Sun Pharmaceutical Company Details
Table 82. Sun Pharmaceutical Business Overview
Table 83. Sun Pharmaceutical Hypoparathyroidism Treatment Product
Table 84. Sun Pharmaceutical Revenue in Hypoparathyroidism Treatment Business (2016-2021) & (US$ Million)
Table 85. Sun Pharmaceutical Recent Development
Table 86. AbbVie Company Details
Table 87. AbbVie Business Overview
Table 88. AbbVie Hypoparathyroidism Treatment Product
Table 89. AbbVie Revenue in Hypoparathyroidism Treatment Business (2016-2021) & (US$ Million)
Table 90. AbbVie Recent Development
Table 91. GlaxoSmithKline Company Details
Table 92. GlaxoSmithKline Business Overview
Table 93. GlaxoSmithKline Hypoparathyroidism Treatment Product
Table 94. GlaxoSmithKline Revenue in Hypoparathyroidism Treatment Business (2016-2021) & (US$ Million)
Table 95. GlaxoSmithKline Recent Development
Table 96. Takeda Pharmaceutical Company Details
Table 97. Takeda Pharmaceutical Business Overview
Table 98. Takeda Pharmaceutical Revenue in Hypoparathyroidism Treatment Business (2016-2021) & (US$ Million)
Table 99. Takeda Pharmaceutical Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hypoparathyroidism Treatment Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Parenteral Features
Figure 4. Global Hypoparathyroidism Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Hypoparathyroidism Treatment Report Years Considered
Figure 9. Global Hypoparathyroidism Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Hypoparathyroidism Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Hypoparathyroidism Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Hypoparathyroidism Treatment Market Share by Regions (2022-2027)
Figure 13. Global Hypoparathyroidism Treatment Market Share by Players in 2020
Figure 14. Global Top Hypoparathyroidism Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypoparathyroidism Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Hypoparathyroidism Treatment Revenue in 2020
Figure 16. Global Hypoparathyroidism Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Hypoparathyroidism Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Hypoparathyroidism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Hypoparathyroidism Treatment Market Share by Type (2016-2027)
Figure 20. North America Hypoparathyroidism Treatment Market Share by Application (2016-2027)
Figure 21. North America Hypoparathyroidism Treatment Market Share by Country (2016-2027)
Figure 22. United States Hypoparathyroidism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Hypoparathyroidism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Hypoparathyroidism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Hypoparathyroidism Treatment Market Share by Type (2016-2027)
Figure 26. Europe Hypoparathyroidism Treatment Market Share by Application (2016-2027)
Figure 27. Europe Hypoparathyroidism Treatment Market Share by Country (2016-2027)
Figure 28. Germany Hypoparathyroidism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Hypoparathyroidism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Hypoparathyroidism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Hypoparathyroidism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Hypoparathyroidism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Hypoparathyroidism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Hypoparathyroidism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Hypoparathyroidism Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Hypoparathyroidism Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Hypoparathyroidism Treatment Market Share by Region (2016-2027)
Figure 38. China Hypoparathyroidism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Hypoparathyroidism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Hypoparathyroidism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Hypoparathyroidism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Hypoparathyroidism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Hypoparathyroidism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Hypoparathyroidism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Hypoparathyroidism Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Hypoparathyroidism Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Hypoparathyroidism Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Hypoparathyroidism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Hypoparathyroidism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Hypoparathyroidism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Hypoparathyroidism Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Hypoparathyroidism Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Hypoparathyroidism Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Hypoparathyroidism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Hypoparathyroidism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Hypoparathyroidism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Takeda Revenue Growth Rate in Hypoparathyroidism Treatment Business (2016-2021)
Figure 58. Roche Revenue Growth Rate in Hypoparathyroidism Treatment Business (2016-2021)
Figure 59. Entera Bio Revenue Growth Rate in Hypoparathyroidism Treatment Business (2016-2021)
Figure 60. Teva Pharmaceuticals Revenue Growth Rate in Hypoparathyroidism Treatment Business (2016-2021)
Figure 61. Sun Pharmaceutical Revenue Growth Rate in Hypoparathyroidism Treatment Business (2016-2021)
Figure 62. AbbVie Revenue Growth Rate in Hypoparathyroidism Treatment Business (2016-2021)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Hypoparathyroidism Treatment Business (2016-2021)
Figure 64. Takeda Pharmaceutical Revenue Growth Rate in Hypoparathyroidism Treatment Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

以下、関連資料のご紹介

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の色汗症治療市場規模・現状・予測（2021年-2027年）

Global Chromhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5658 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、色汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アポクリン色汗症、エクリン色汗症、偽色汗症）、用途別市場規模（病院＆診療所、専門医＆皮膚科医院、その他）、主要地域別市場規模（北米、アメリカ、...

世界の天然痘治療市場規模・現状・予測（2021年-2027年）

Global Smallpox Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6015 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、天然痘治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、ワクチン）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の総胆管結石症治療市場規模・現状・予測（2021年-2027年）

Global Choledocholithiasis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4004 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、総胆管結石症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科的治療）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界のウィルムス腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Wilms' Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6071 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ウィルムス腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カボザンチニブ、SEL-12034、ラコツモマブ、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界の中毒治療市場規模・現状・予測（2021年-2027年）

Global Poisoning Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4727 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、中毒治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（解毒剤、胃洗浄、浣腸、血液透析、その他）、用途別市場規模（病院、救急センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の痙性斜頸治療市場規模・現状・予測（2021年-2027年）

Global Cervical Dystonia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5653 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、痙性斜頸治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ボツリヌス菌、抗コリン作用薬、ドーパミン作動薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（...

世界の肝腎症候群治療市場規模・現状・予測（2021年-2027年）

Global Hepatorenal Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4305 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、肝腎症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヘパトレン、テルリバズ、グリプレシン、ルカシン、その他）、用途別市場規模（1型肝腎症候群、2型肝腎症候群）、主要地域別市場規模（北米、アメ...

世界の睡眠麻痺治療市場規模・現状・予測（2021年-2027年）

Global Sleep Paralysis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4872 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、睡眠麻痺治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（覚醒剤、選択的セロトニン再取り込み阻害薬（SSRI）、三環系抗うつ薬、オキシベートナトリウム）、用途別市場規模（病院、家庭、介護センター、そ...

世界のピーナッツアレルギー治療市場規模・現状・予測（2021年-2027年） Peanuts are important food allergens and can cause extremely severe allergies. Symptoms of peanut allergy include: reduced blood pressure, swelling of the face and throat, which can hinder breathing and cause shock. Market Analysis and Insights: Global Peanut Allergy Treatment Market The global Pean…
世界の尿素サイクル異常症（UCD）治療市場規模・現状・予測（2021年-2027年） The urea cycle disorders are hereditary metabolic disorders caused by a deficiency of one of the enzymes in the urea cycle responsible for removing ammonia from the bloodstream. Market Analysis and Insights: Global Urea Cycle Disorders (UCD) Treatment Market The global Urea Cycle Disorders (UCD) Tre…
世界の静脈性潰瘍治療市場規模・現状・予測（2021年-2027年） Vascular ulcer is also known as stasis ulcer, venous insufficiency, stasis dermatitis, varicose ulcer, or ulcus cruris. Vascular ulcer is caused due to abnormal vein functions. Ulcers are commonly diagnosed in people of ages 65 or more. The ulcers of lower extremities are a typical reason for a visi…
世界のウイルス性肺炎治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Viral Pneumonia Treatment Drugs Market The global Viral Pneumonia Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data i…
世界の小児HIV感染症治療市場規模・現状・予測（2021年-2027年） Over 1.8 million children across the globe are affected from HIV, while only half of these have access to the antiretroviral therapy (ART), according to the UNICEF Market Analysis and Insights: Global Pediatric HIV Infection Treatment Market The global Pediatric HIV Infection Treatment market size i…